FTSE All-Share

FTSE All-Share handeln
5.492,37 PKT -28,58 PKT -0,52 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
22.09.15 HSBC Neutral Goldman Sachs Group Inc.
22.09.15 BT Group Neutral Nomura
21.09.15 Sky Neutral Goldman Sachs Group Inc.
21.09.15 Vodafone Group Neutral Goldman Sachs Group Inc.
21.09.15 Imperial Brands Neutral Citigroup Corp.
21.09.15 BAT buy Citigroup Corp.
21.09.15 Prudential Hold Jefferies & Company Inc.
18.09.15 AstraZeneca kaufen UBS AG
18.09.15 GSK buy Goldman Sachs Group Inc.
18.09.15 Glencore Outperform BNP PARIBAS
18.09.15 Rio Tinto Neutral BNP PARIBAS
17.09.15 Glencore Halten Independent Research GmbH
17.09.15 Rio Tinto buy Citigroup Corp.
17.09.15 Vodafone Group overweight Morgan Stanley
17.09.15 Unilever Sell Goldman Sachs Group Inc.
17.09.15 Unilever Sell Goldman Sachs Group Inc.
17.09.15 BAT Neutral Goldman Sachs Group Inc.
17.09.15 Diageo Sell Goldman Sachs Group Inc.
17.09.15 Glencore Hold Deutsche Bank AG
17.09.15 Glencore Neutral Goldman Sachs Group Inc.
17.09.15 Prudential buy UBS AG
16.09.15 BAT Equal-Weight Morgan Stanley
16.09.15 GSK Neutral BNP PARIBAS
16.09.15 Vodafone Group buy Deutsche Bank AG
16.09.15 BT Group Hold Deutsche Bank AG
16.09.15 BAT overweight JP Morgan Chase & Co.
16.09.15 Glencore Neutral JP Morgan Chase & Co.
16.09.15 Glencore Neutral Goldman Sachs Group Inc.
16.09.15 Barclays Conviction Buy Goldman Sachs Group Inc.
15.09.15 Unilever Reduce Nomura
15.09.15 BP Neutral BNP PARIBAS
15.09.15 Vodafone Group Neutral Goldman Sachs Group Inc.
14.09.15 Glencore overweight Barclays Capital
14.09.15 HSBC Neutral JP Morgan Chase & Co.
14.09.15 Glencore Hold Jefferies & Company Inc.
14.09.15 Vodafone Group buy Nomura
11.09.15 Shell (ex Royal Dutch Shell) buy Jefferies & Company Inc.
11.09.15 BP Hold Jefferies & Company Inc.
11.09.15 Sky buy Citigroup Corp.
11.09.15 AstraZeneca Neutral JP Morgan Chase & Co.